From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape
Joshua Yang, Co-founder & CEO of Glyphic Biotechnologies and Co-founder of NephroSant, sat down with me to explore the applications of next-generation protein sequencing for biomedical research and clinical medicine, his journey from academia to entrepreneurship, and much more.
